Neutral sphingomyelinase 2 deficiency is associated with lung anomalies similar to emphysema

Christophe Poirier, Evgeny V. Berdyshev, Christiana Dimitropoulou, Natalia V. Bogatcheva, Paul W. Biddinger, Alexander D. Verin

Research output: Contribution to journalArticle

11 Scopus citations


Neutral sphingomyelinase 2 (nSMase2) upregulation was recently demonstrated to serve as a molecular link between smoke inhalation and emphysematous changes in lungs. Here we report that nSMase2 deficit impairs lung development in mice. We have shown previously that fragilitas ossium (fro) mice carry a mutation in the Smpd3 gene, rendering nSMase2 catalytically inactive. Analysis of lung phenotype revealed that fro mice have abnormally enlarged alveoli and increased compliance of the respiratory system, similar to morphological and functional manifestations of emphysema. Analysis of sphingolipid content in fro lungs revealed a decreased level of C14:0 ceramide but no significant alterations in the levels of sphingosine or sphingosine-1-phosphate. Altogether, our data suggest that nSMase2 activity and ceramide level are critical for lung development and function. Based on our data, ceramide can no longer be viewed as a lipid solely detrimental to lung function.

Original languageEnglish (US)
Pages (from-to)758-763
Number of pages6
JournalMammalian Genome
Issue number11-12
StatePublished - Dec 1 2012


ASJC Scopus subject areas

  • Genetics

Cite this

Poirier, C., Berdyshev, E. V., Dimitropoulou, C., Bogatcheva, N. V., Biddinger, P. W., & Verin, A. D. (2012). Neutral sphingomyelinase 2 deficiency is associated with lung anomalies similar to emphysema. Mammalian Genome, 23(11-12), 758-763.